Skip to main content
Tuesday, July 23, 2024 - 11:08am
Lockheed Martin

Lockheed Martin Corp reported strong Q2 2024 results, with net sales up 9% YoY, adjusted EPS of $7.11, and backlog of $158.342 billion. FY24 outlook raised.

Read more
Tuesday, July 23, 2024 - 11:03am
crypto movers image

Over the past 24 hours, Arbitrum's (CRYPTO: ARB) price has risen 5.3% to $0.81. This continues its positive trend over the past week where it has experienced a 6.0% gain, moving from $0.75 to its current price. As it stands right now, the coin's all-time high is $2.39.

Read more
Tuesday, July 23, 2024 - 11:02am
crypto movers image

Over the past 24 hours, Artificial Superintelligence Alliance's (CRYPTO: FET) price has fallen 3.27% to $1.34. This continues its negative trend over the past week where it has experienced a 7.0% loss, moving from $1.41 to its current price.

Read more
Tuesday, July 23, 2024 - 11:02am
crypto movers image

Over the past 24 hours, Ethereum Classic's (CRYPTO: ETC) price has risen 5.44% to $24.54. This continues its positive trend over the past week where it has experienced a 3.0% gain, moving from $23.45 to its current price.

Read more
Tuesday, July 23, 2024 - 11:01am
crypto movers image

NEAR Protocol's (CRYPTO: NEAR) price has decreased 3.19% over the past 24 hours to $5.94, continuing its downward trend over the past week of -5.0%, moving from $6.15 to its current price.

Read more
Tuesday, July 23, 2024 - 11:00am
crypto movers image

Polkadot's (CRYPTO: DOT) price has decreased 3.13% over the past 24 hours to $6.03, continuing its downward trend over the past week of -7.0%, moving from $6.41 to its current price.

Read more
Tuesday, July 23, 2024 - 10:54am
GPC

Genuine Parts shares fell after Q2 FY24 earnings missed expectations and the outlook turned grim. Sales grew 0.85% year-on-year to $5.963 billion, missing the $6.047 billion consensus.

Read more
Tuesday, July 23, 2024 - 10:49am
BZ Pharma Briefs

Cellectar Biosciences stock drops 19.2% following the release of CLOVER WaM study results. The pivotal study for iopofosine I 131 in relapsed/refractory Waldenstrom's macroglobulinemia showed an 80% overall response rate.

Read more
Tuesday, July 23, 2024 - 10:46am
KMB

Kimberly-Clark (NYSE: KMB) disappoints with Q2 revenue miss despite EPS growth; cites currency impacts and business divestiture challenges.

Read more